Every one of those 1 sits in a single category, pharma. EPA is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Tony Evers, all published on March 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Tony Evers
Every one of those 1 sits in a single category, pharma. EPA is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Tony Evers, all published on March 18, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Tony Evers. Shared-story counts are live from our verified record — not editorial picks.
The Wisconsin Senate has passed a comprehensive $133 million legislative package aimed at combating per- and polyfluoroalkyl substances (PFAS), commonly known as 'forever chemicals.' The bills now head to Governor Tony Evers' desk, marking a significant state-level intervention in environmental toxicology and public health infrastructure.
Tony Evers is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.